{"id":"NCT03022045","sponsor":"AbbVie","briefTitle":"A Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis","officialTitle":"A Phase 3, Randomized, Open-Label Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-01-26","primaryCompletion":"2017-09-17","completion":"2020-11-19","firstPosted":"2017-01-16","resultsPosted":"2019-02-06","lastUpdate":"2021-11-18"},"enrollment":18,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Psoriasis"],"interventions":[{"type":"DRUG","name":"risankizumab","otherNames":["ABBV-066 BI 655066"]}],"arms":[{"label":"Risankizumab 75 mg","type":"EXPERIMENTAL"},{"label":"Risankizumab 150 mg","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to investigate the safety and efficacy of two different dose regimens of risankizumab for Japanese subjects with generalized pustular psoriasis (GPP) or erythrodermic psoriasis (EP).","primaryOutcome":{"measure":"Percentage of Participants With Generalized Pustular Psoriasis (GPP) Achieving GPP Clinical Response at Week 16","timeFrame":"Week 16","effectByArm":[{"arm":"GPP Risankizumab 75 mg","deltaMin":100,"sd":null},{"arm":"GPP Risankizumab 150 mg","deltaMin":100,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":5},"locations":{"siteCount":9,"countries":["Japan"]},"refs":{"pmids":["31667790"],"seeAlso":["https://www.abbvie.com/content/dam/abbvie-dotcom/us/clinical-trials/risankizumab_M15-988.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":4},"commonTop":["Viral upper respiratory tract infection","Constipation","Hepatic function abnormal","Otitis media","Dehydration"]}}